Worth reading
54Recurring
Scored from 3 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
2
LocationWording
Avoiding a definitive answer
How definitive the wording is.This transaction
Acquisition of the BusinessCounterparty (target company)株式会社ファインズファルマ
Disclosing companyMedical Ikkou Group Co.,Ltd.
Contract Date30 June 2026
Execution Date / Effective DateTo be determined
Target company
2 dispensing pharmacies
Location Showa-ku, Nagoya, Aichi Prefecture
Impact on Business Performance
The impact of this transaction on the consolidated results of the Company’s group will be immaterial.
Procedures and assumptions
Conditions Precedent to ExecutionCoordination of the various conditions required for execution and completion of the necessary procedures
| Item | Details |
|---|---|
| Transaction name | Acquisition of the Business |
| Counterparty name | 株式会社ファインズファルマ |
| Name of the Subject Company | 株式会社ファインズファルマ |
| Business Description of the Subject Company | 2 dispensing pharmacies |
| Location of the Subject Company | Showa-ku, Nagoya, Aichi Prefecture |
| Impact on Business Performance | The impact of this transaction on the consolidated results of the Company’s group will be immaterial. |
| Contract Date | 30 June 2026 |
| Execution Date / Effective Date | To be determined |
| Conditions Precedent to Execution | Coordination of the various conditions required for execution and completion of the necessary procedures |
Items this document does not state (23)
Capital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionValuation methodologyIndependent valuation institutionSpecial CommitteeManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because coordinating the various conditions required for execution is taking time.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.